SPOTLIGHT: Are pharma relationship limits curbing research?

Are pharma relationship limits curbing research?
As pressure mounts to regulate physician relationships with pharmaceutical companies, some doctor have begun to push back, arguing that there are tangible, patient-friendly benefits to such relationships. Some say that conflict-of-interest rules are making legitimate medical research difficult. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.